Ten‐Year Trend of Oral Anticoagulation Use in Postoperative and Nonpostoperative Atrial Fibrillation in Routine Clinical Practice

Background The study aimed to describe the patterns and trends of initiation, discontinuation, and adherence of oral anticoagulation (OAC) in patients with new‐onset postoperative atrial fibrillation (POAF), and compare with patients newly diagnosed with non‐POAF. Methods and Results This retrospect...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaoxi Yao, Holly K. Van Houten, Konstantinos C. Siontis, Paul A. Friedman, Robert D. McBane, Bernard J. Gersh, Peter A. Noseworthy
Format: Article
Language:English
Published: Wiley 2024-07-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.124.035708
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850150412105023488
author Xiaoxi Yao
Holly K. Van Houten
Konstantinos C. Siontis
Paul A. Friedman
Robert D. McBane
Bernard J. Gersh
Peter A. Noseworthy
author_facet Xiaoxi Yao
Holly K. Van Houten
Konstantinos C. Siontis
Paul A. Friedman
Robert D. McBane
Bernard J. Gersh
Peter A. Noseworthy
author_sort Xiaoxi Yao
collection DOAJ
description Background The study aimed to describe the patterns and trends of initiation, discontinuation, and adherence of oral anticoagulation (OAC) in patients with new‐onset postoperative atrial fibrillation (POAF), and compare with patients newly diagnosed with non‐POAF. Methods and Results This retrospective cohort study identified patients newly diagnosed with atrial fibrillation or flutter between 2012 and 2021 using administrative claims data from OptumLabs Data Warehouse. The POAF cohort included 118 366 patients newly diagnosed with atrial fibrillation or flutter within 30 days after surgery. The non‐POAF cohort included the remaining 315 832 patients who were newly diagnosed with atrial fibrillation or flutter but not within 30 days after a surgery. OAC initiation increased from 28.9% to 44.0% from 2012 to 2021 in POAF, and 37.8% to 59.9% in non‐POAF; 12‐month medication adherence increased from 47.0% to 61.8% in POAF, and 59.7% to 70.4% in non‐POAF. The median time to OAC discontinuation was 177 days for POAF, and 242 days for non‐POAF. Patients who saw a cardiologist within 90 days of the first atrial fibrillation or flutter diagnosis, regardless of POAF or non‐POAF, were more likely to initiate OAC (odds ratio, 2.92 [95% CI, 2.87–2.98]; P <0.0001), adhere to OAC (odds ratio, 1.08 [95% CI, 1.04–1.13]; P <0.0001), and less likely to discontinue (odds ratio, 0.83 [95% CI, 0.82–0.85]; P <0.0001) than patients who saw a surgeon or other specialties. Conclusions The use of and adherence to OAC were higher in non‐POAF patients than in POAF patients, but they increased over time in both groups. Patients managed by cardiologists were more likely to use and adhere to OAC, regardless of POAF or non‐POAF.
format Article
id doaj-art-fb89eb16ec834e29830684dce23dcee8
institution OA Journals
issn 2047-9980
language English
publishDate 2024-07-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj-art-fb89eb16ec834e29830684dce23dcee82025-08-20T02:26:33ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802024-07-01131310.1161/JAHA.124.035708Ten‐Year Trend of Oral Anticoagulation Use in Postoperative and Nonpostoperative Atrial Fibrillation in Routine Clinical PracticeXiaoxi Yao0Holly K. Van Houten1Konstantinos C. Siontis2Paul A. Friedman3Robert D. McBane4Bernard J. Gersh5Peter A. Noseworthy6Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery Mayo Clinic Rochester MNRobert D. and Patricia E. Kern Center for the Science of Health Care Delivery Mayo Clinic Rochester MNDepartment of Cardiovascular Medicine Mayo Clinic Rochester MNDepartment of Cardiovascular Medicine Mayo Clinic Rochester MNDepartment of Cardiovascular Medicine Mayo Clinic Rochester MNDepartment of Cardiovascular Medicine Mayo Clinic Rochester MNDepartment of Cardiovascular Medicine Mayo Clinic Rochester MNBackground The study aimed to describe the patterns and trends of initiation, discontinuation, and adherence of oral anticoagulation (OAC) in patients with new‐onset postoperative atrial fibrillation (POAF), and compare with patients newly diagnosed with non‐POAF. Methods and Results This retrospective cohort study identified patients newly diagnosed with atrial fibrillation or flutter between 2012 and 2021 using administrative claims data from OptumLabs Data Warehouse. The POAF cohort included 118 366 patients newly diagnosed with atrial fibrillation or flutter within 30 days after surgery. The non‐POAF cohort included the remaining 315 832 patients who were newly diagnosed with atrial fibrillation or flutter but not within 30 days after a surgery. OAC initiation increased from 28.9% to 44.0% from 2012 to 2021 in POAF, and 37.8% to 59.9% in non‐POAF; 12‐month medication adherence increased from 47.0% to 61.8% in POAF, and 59.7% to 70.4% in non‐POAF. The median time to OAC discontinuation was 177 days for POAF, and 242 days for non‐POAF. Patients who saw a cardiologist within 90 days of the first atrial fibrillation or flutter diagnosis, regardless of POAF or non‐POAF, were more likely to initiate OAC (odds ratio, 2.92 [95% CI, 2.87–2.98]; P <0.0001), adhere to OAC (odds ratio, 1.08 [95% CI, 1.04–1.13]; P <0.0001), and less likely to discontinue (odds ratio, 0.83 [95% CI, 0.82–0.85]; P <0.0001) than patients who saw a surgeon or other specialties. Conclusions The use of and adherence to OAC were higher in non‐POAF patients than in POAF patients, but they increased over time in both groups. Patients managed by cardiologists were more likely to use and adhere to OAC, regardless of POAF or non‐POAF.https://www.ahajournals.org/doi/10.1161/JAHA.124.035708adherenceoral anticoagulationpostoperative atrial fibrillation
spellingShingle Xiaoxi Yao
Holly K. Van Houten
Konstantinos C. Siontis
Paul A. Friedman
Robert D. McBane
Bernard J. Gersh
Peter A. Noseworthy
Ten‐Year Trend of Oral Anticoagulation Use in Postoperative and Nonpostoperative Atrial Fibrillation in Routine Clinical Practice
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
adherence
oral anticoagulation
postoperative atrial fibrillation
title Ten‐Year Trend of Oral Anticoagulation Use in Postoperative and Nonpostoperative Atrial Fibrillation in Routine Clinical Practice
title_full Ten‐Year Trend of Oral Anticoagulation Use in Postoperative and Nonpostoperative Atrial Fibrillation in Routine Clinical Practice
title_fullStr Ten‐Year Trend of Oral Anticoagulation Use in Postoperative and Nonpostoperative Atrial Fibrillation in Routine Clinical Practice
title_full_unstemmed Ten‐Year Trend of Oral Anticoagulation Use in Postoperative and Nonpostoperative Atrial Fibrillation in Routine Clinical Practice
title_short Ten‐Year Trend of Oral Anticoagulation Use in Postoperative and Nonpostoperative Atrial Fibrillation in Routine Clinical Practice
title_sort ten year trend of oral anticoagulation use in postoperative and nonpostoperative atrial fibrillation in routine clinical practice
topic adherence
oral anticoagulation
postoperative atrial fibrillation
url https://www.ahajournals.org/doi/10.1161/JAHA.124.035708
work_keys_str_mv AT xiaoxiyao tenyeartrendoforalanticoagulationuseinpostoperativeandnonpostoperativeatrialfibrillationinroutineclinicalpractice
AT hollykvanhouten tenyeartrendoforalanticoagulationuseinpostoperativeandnonpostoperativeatrialfibrillationinroutineclinicalpractice
AT konstantinoscsiontis tenyeartrendoforalanticoagulationuseinpostoperativeandnonpostoperativeatrialfibrillationinroutineclinicalpractice
AT paulafriedman tenyeartrendoforalanticoagulationuseinpostoperativeandnonpostoperativeatrialfibrillationinroutineclinicalpractice
AT robertdmcbane tenyeartrendoforalanticoagulationuseinpostoperativeandnonpostoperativeatrialfibrillationinroutineclinicalpractice
AT bernardjgersh tenyeartrendoforalanticoagulationuseinpostoperativeandnonpostoperativeatrialfibrillationinroutineclinicalpractice
AT peteranoseworthy tenyeartrendoforalanticoagulationuseinpostoperativeandnonpostoperativeatrialfibrillationinroutineclinicalpractice